Regenicin, Inc. Income (Loss) from Continuing Operations, Per Basic and Diluted Share
Regenicin, Inc. reported Income (Loss) from Continuing Operations, Per Basic and Diluted Share of $0.00 per share for the 3-month period ending 2021-12-31, per its 10-Q/A filed 2022-03-25.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare · last filed 2022-03-25
- Regenicin, Inc. income (loss) from continuing operations, per basic and diluted share for the quarter ending 2021-12-31 was $0.00.
- Regenicin, Inc. income (loss) from continuing operations, per basic and diluted share for the quarter ending 2020-12-31 was $0.00.
| Period end | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 3 month |
|---|---|
| 2021-12-31 | $0.00 10-Q/A · filed 2022-03-25 |
| 2020-12-31 | $0.00 10-Q/A · filed 2022-03-25 |